Is the combination of chromogranin A and pancreatic polypeptide serum determinations of interest in the diagnosis and follow-up of gastro-entero-pancreatic neuroendocrine tumours?-Reference-Cited by-同舟云学术

Is the combination of chromogranin A and pancreatic polypeptide serum determinations of interest in the diagnosis and follow-up of gastro-entero-pancreatic neuroendocrine tumours?

Published:2012-08 Issue:12 Volume:48 Page:1766-1773
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Walter Thomas,Chardon Laurence,Chopin-laly Xavier,Raverot Véronique,Caffin Anne-Gaelle,Chayvialle Jean-Alain,Scoazec Jean-Yves,Lombard-Bohas Catherine

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers;O’Toole;Neuroendocrinology,2009

2. Chromogranin A – biological function and clinical utility in neuroendocrine tumor disease;Modlin;Ann Surg Oncol,2010

3. Diagnostic value of plasma chromogranin A in neuroendocrine tumours;Tomassetti;Eur J Gastroenterol Hepatol,2001

4. Chromogranin A: is it a useful marker of neuroendocrine tumors?;Campana;J Clin Oncol,2007

5. Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours;Baudin;Br J Cancer,1998

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A neuroendocrine biomarker revolution from monoanalyte to multianalyte biomarkers in non-functioning gastro-entero-pancreatic neuroendocrine neoplasms;Critical Reviews in Oncology/Hematology;2024-11

2. Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives;Military Medical Research;2024-06-04

3. Diagnostic Challenges in Pancreatic Tumors;IgMin Research;2024-05-13

4. Investigating Carcinoid Tumor Oncogenesis through the lens of Developmental Dynamics involved in Small Intestinal Neuroendocrine Cells;2024-03-29

5. The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective;Current Treatment Options in Oncology;2023-11-22